Zobrazeno 1 - 2
of 2
pro vyhledávání: '"политика «прозрачности»"'
Publikováno v:
Clinical pharmacy; Vol. 25 No. 1 (2021); 32-40
Клиническая фармация; Том 25 № 1 (2021); 32-40
Клінічна фармація; Том 25 № 1 (2021); 32-40
Клиническая фармация; Том 25 № 1 (2021); 32-40
Клінічна фармація; Том 25 № 1 (2021); 32-40
Providing the population of Ukraine with quality, effective and, at the same time, economically affordable medicines is a priority task of the healthcare system. Taking into account the relatively low cost of their development generic drugs are avail
Publikováno v:
Clinical pharmacy; Vol. 25 No. 1 (2021); 32-40
Клиническая фармация; Том 25 № 1 (2021); 32-40
Клінічна фармація; Том 25 № 1 (2021); 32-40
Клиническая фармация; Том 25 № 1 (2021); 32-40
Клінічна фармація; Том 25 № 1 (2021); 32-40
Providing the population of Ukraine with quality, effective and, at the same time, economically affordable medicines is a priority task of the healthcare system. Taking into account the relatively low cost of their development generic drugs are avail